BETA
Swiss medical device company behind SupraFusion ultrasonic technology for soft tissue-to-bone fixation.
Surgical Fusion Technologies is a Schlieren, Switzerland medical device company led by CEO Till Gumz. Its SupraFusion brand combines bioresorbable implants, ultrasonic insertion hardware and surgical instrumentation for soft tissue-to-bone fixation.
The SF Push-in Anchor is inserted with the SupraFuser ultrasonic system. Ultrasonic energy locally softens the implant surface so it interlocks with surrounding cancellous bone. The portfolio is focused on orthopedic fixation and ligament or tendon repair rather than a general-purpose ultrasound treatment platform.
The company has U.S. 510(k) clearances for SF Push-in Anchor configurations and is pursuing further materials research through the AFUBI programme. New biomaterial concepts and grant-funded development should be distinguished from the products and indications already covered by clearance.
FDA cleared SF Push-in Anchor submissions K240288 on April 1, 2024 and K260294 on March 27, 2026. These are 510(k) clearances rather than PMA approvals. The indications and permitted anchor configurations should be read from the individual submissions. [8][7][2][3]
The SupraFuser generator and instruments are used with the anchor system. Research into bioactive fibers and other next-generation materials does not establish clearance for every proposed material or future sports-medicine application. [8][7][2][3]
Latest recorded source review: 2026-11-05.
Scope: selected product families.
Documented commercial product families.
Bioresorbable anchor configurations inserted using ultrasonic energy from the SupraFuser system for suture or tissue fixation. U.S. labeling specifies permitted anatomical applications and configurations. [7][2][3]
Commercial · U.S. 510(k)-cleared anchor system
Ultrasonic generator, handpiece and associated instruments used to insert SF Push-in Anchors. It is part of the anchor insertion system, not an independently cleared therapeutic-ultrasound indication. [7]
Commercial · Component of the anchor insertion systemFDA cleared SF Push-in Anchor submission K260294. [3]
FDA cleared K240288 for the anchor system. [2]
Accessed 11/05/2026